Annual Revenue ($)
Medtronic revenue was $29.95 b in FY, 2018 which is a 0.8% year over year increase from the previous period.
Quarterly Revenue ($)
Annual Growth Rate (%)
Revenue Breakdown
Business Segment
Geographic Segment
Medtronic revenue breakdown by business segment: 7.1% from Diabetes Group, 25.9% from Restorative Therapies Group, 37.9% from Cardiac and Vascular Group and 29.1% from Minimally Invasive Therapies Group
Medtronic revenue breakdown by geographic segment: 46.7% from Rest of World, 53.0% from United States and 0.3% from Other
| FY, 2016 | FY, 2017 | FY, 2018 | |
|---|---|---|---|
| Diabetes Group | 1.86 b | 1.93 b | 2.14 b |
| Restorative Therapies Group | 7.21 b | 7.37 b | 7.74 b |
| Cardiac and Vascular Group | 10.20 b | 10.50 b | 11.35 b |
| Minimally Invasive Therapies Group | 9.56 b | 9.92 b | 8.72 b |
| FY, 2016 | FY, 2017 | FY, 2018 | |
|---|---|---|---|
| Rest of World | 12.33 b | 12.98 b | 13.99 b |
| Ireland | 79 m | 69 m | 85 m |
| United States | 16.42 b | 16.66 b | 15.88 b |
Report incorrect company information
